Akouos
company
About
Akouos is a biotechnology company focusing on restoring and preserving hearing.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $105M
- Industries
- Biotechnology,Health Diagnostics,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$105M
Akouos has raised a total of
$105M
in funding over 2 rounds. Their latest funding was raised on
Mar 3, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 3, 2020 | Series B | $105M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Akouos is funded by 1 investors.
Polaris Founders Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Polaris Founders Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
